Chargement en cours...
STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits
Clinically, HER2 proto-oncogene amplification is found in about 25–30% of human breast cancers, where it is correlated to a poor prognosis. Constitutive STAT3 activation is found in about 50–60% of the breast tumors and associated with tumorigenesis and drug resistance. In this study, we showed that...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
D.A. Spandidos
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3898805/ https://ncbi.nlm.nih.gov/pubmed/24297508 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2013.2195 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|